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Abstract: Hypoxic conditions induce the activation of hypoxia-inducible factor-1α (HIF-1α) to restore
the supply of oxygen to tissues and cells. Activated HIF-1α translocates into the nucleus and binds
to hypoxia response elements to promote the transcription of target genes. Cathepsin L (CTSL) is
a lysosomal protease that degrades cellular proteins via the endolysosomal pathway. In this study,
we attempted to determine if CTSL is a hypoxia responsive target gene of HIF-1α, and decipher
its role in melanocytes in association with the autophagic pathway. The results of our luciferase
reporter assay showed that the expression of CTSL is transcriptionally activated through the binding
of HIF1-α at its promoter. Under autophagy-inducing starvation conditions, HIF-1α and CTSL
expression is highly upregulated in melan-a cells. The mature form of CTSL is closely involved
in melanosome degradation through lysosomal activity upon autophagosome–lysosome fusion.
The inhibition of conversion of pro-CTSL to mature CTSL leads to the accumulation of gp100 and
tyrosinase in addition to microtubule-associated protein 1 light chain 3 (LC3) II, due to decreased
lysosomal activity in the autophagic pathway. In conclusion, we have identified that CTSL, a novel
target of HIF-1α, participates in melanosome degradation in melanocytes through lysosomal activity
during autophagosome–lysosome fusion.
Keywords: Cathepsin L; hypoxia-inducible factor-1-alpha; autophagy; melanosome
1. Introduction
Hypoxia is a state in which tissues are deprived of oxygen supply. Oxygen acts as
a terminal electron acceptor in the mitochondria of cells; thus, a low supply of oxygen is
closely related to the pathology of diseases such as cancer, aging, and diabetes [1]. Cells
recognize changes in oxygen concentration and respond to low oxygen concentrations by
activating hypoxia-inducible factor-1 (HIF-1). HIF-1 is a heterodimer consisting of HIF-1α
(O2-labile) and aryl hydrocarbon receptor nuclear translocator (HIF-1β). Among the HIF-1
subunits, the status of HIF-1α determines the activity of HIF-1 and is known as a tran-
scriptional regulator of the hypoxia-responsive genes that are related to cell proliferation,
survival, death, cytoskeletal structure, and angiogenesis [2]. Under hypoxic or hypoxia
mimicking conditions, accumulated HIF-1α is translocated to the nucleus and binds to
hypoxia response elements (HRE) in the genome containing the sequence 5′-RCGTG-3′ (R,
purine (A or G)) to activate the transcription of target genes, including vascular endothelial
growth factor (VEGF), transforming growth factor-β (TGF-β), and phosphoglycerate kinase
1 (PGK1) [3–5]. Skin has also been reported to be a participant in response to hypoxia.
Although the skin is exposed to air, the epidermal oxygen pressure remains relatively
low. Previous studies have reported that HIF-1α participates in cutaneous angiogenesis,
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skin tumorigenesis, and microbial infection. HIF-1α induces the migration and motility of
dermal fibroblasts and keratinocytes [6,7]. To understand the elaborate network of HIF-1α,
the mechanism of HIF-1α and its target genes needs to be investigated.
Lysosomal proteases participate in protein hydrolysis and are related to diseases
such as cancer, osteoporosis, and Alzheimer’s disease [7–10]. Among the papain family of
cysteine proteinases, cathepsin B (CTSB) is reported to participate in tumor cell proliferation,
angiogenesis, and invasion [11–13], and has been identified as a target of HIF-1α [9].
Cathepsin K (CTSK) plays a role in osteoclast-mediated bone resorption by degrading
bone matrix proteins [9]. Like CTSB and CTSK, cathepsin L (CTSL) is released from the
lysosome, located in endolysosomal vesicles, and acts as an endopeptidase. Based on
these findings, we hypothesized that other cathepsin subtypes, such as CTSL, could be
regulated by HIF-1α as CTSB. Therefore, we manually searched for hypoxia response
elements (HREs) in promoters of CTSL and, as a result, we found three HREs in CTSL
using ApE plasmid Editor.
CTSL is subdivided into CTSL1 and CTSL2 in humans, which are termed CTSL and
CTSV, respectively, in mice [14]. The function of CTSL has been studied in various fields.
CTSL is involved in disease-related cellular processes such as tumor cell migration, process-
ing of antigenic peptides, B cell homeostasis, increased aortic diameters, and arterial wall
remodeling [15–17]. Recently, a relationship between CTSL and coronavirus (SARS-CoV-2)
disease (COVID-19) has been reported. Elevated levels of circulating CTSL in COVID-
19 patients cleave the spike protein of the virus and result in increased virus entry into
cells [18]. Additionally, a previous report has revealed that CTSL is required for normal
hair follicle development, cycling, homeostasis of the interfollicular epidermis, and hair
follicle pigmentation [19]. Tobin et al. has reported that CTSL knockout mice demonstrate
abnormalities in hair canal formation, and melanosomes in the hair follicles become unsta-
ble when CTSL is absent [20]. Accordingly, CTSL is known to play an important role in skin
physiology, such as hair follicles and melanocytes. Although many studies demonstrated
the relationship between CTSL and cellular signaling, there is no report on the role of
CTSL, regulated by HIF-1α, in melanocytes and fibroblasts. Thus, we have first shown
that HIF-1α regulates CTSL expression using the melan-a cells through a luciferase gene
reporter assay. In addition, HIF-1α-regulated CTSL expression in melanocytes participates
in melanosome homeostasis through the lysosomal and autophagic pathways.
2. Results
2.1. Hypoxia Condition Induces the Nuclear Expression of HIF-1α Protein and CTSL Expression
in Melan-a Cells
The translocation of HIF-1 α into the nucleus was evaluated under hypoxia conditions.
As shown in Figure 1a, hypoxia enhanced yhr nuclear fractions of HIF-1 α protein. In addi-
tion, CTSL mRNA (Figure 1b) and protein (Figure 1c) were induced by hypoxia environ-
ment. Next, we detected three candidate consensus HREs (RCGTG, R, purine (A or G)) in
the murine CTSL promoter (Figure 1d) and designed a luciferase reporter construct contain-
ing murine CTSL with HREs (pGL3-Ctsl/HRE) and mutated HREs (pGL3-Ctsl/mutHRE).
Luciferase assay results demonstrate that cells transfected with wild-type construct (pGL3-
Ctsl/HRE) showed higher luciferase activity in hypoxia conditions compared to normoxia
(Figure 1e). However, mutant construct (pGL3-Ctsl/mutHRE)-transfected cells did not
show incremental activity under hypoxia. To confirm the interaction between HIF-1 α and
CTSL promoter in melan-a cells, chromatin immunoprecipitation was performed. Since the
CTSL promoter contains three candidate consensus HREs, we tested three different sites
to detect interaction. Figure 1f shows that HIF-1α bound to all three sites under hypoxia
conditions. Based on these results, CTSL transcription was induced by HIF-1α binding to
the predicted sequence in the CTSL promoter.
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Figure 1. Hypoxic condition enhanced HIF-1α and CTSL activation. (a) Western blotting analysis of cytosolic and nuclear 
fractions of HIF-1α under normoxic or hypoxic conditions. mRNA (b) and protein (c) levels of CTSL were assessed in 
melan-a cells in hypoxia. (d) HREs in CTSL promoter were predicted. (e) Cells were transfected with luciferase reporter 
vectors, pGL3-Ctsl/HRE or pGL3-Ctsl/mutHRE, and luciferase activity was determined under hypoxic conditions for 4 h. 
(f) ChIP-qPCR analysis for HIF1-α occupancy on CTSL promoter in melan-a cells in normoxa or hypoxia for 4 h. Quanti-
fication of enrichment was represented as fold-enrichment relative to IgG. Results are expressed as mean ± S.D of more 
than three independent experiments. * p < 0.05. Student’s t-test. 
2.2. Hypoxia Mimicking Condition by DFO Treatment Also Stimulated the Nuclear Expression 
of HIF-1α Protein and CTSL Expression in Melan-a Cells 
Deferoxamine (DFO), an iron chelator, is known to upregulate the expression of HIF-
1α by mimicking the hypoxic environment [14,21]. The findings of cell viability assays 
indicate that DFO treatment does not induce cytotoxicity at concentrations below 100 μM 
(Figure S1a). Furthermore, the DFO treatment of melan-a cells significantly increased the 
nuclear expression of HIF-1α protein (Figure S1b) and CTSL transcripts (Figure S1c). 
Moreover, the protein levels of CTSL and LC3 II were increased after DFO treatment (Fig-
ure S1d). These results indicate that DFO induces HIF-1α and CTSL in melan-a cells. 
  
Figure 1. Hypoxic condition enhanced HIF-1α and CTSL activation. (a) Western blotting analysis of cytosolic and nuclear
fractions of HIF-1α under normoxic or hypoxic conditions. mRNA (b) and protein (c) levels of CTSL were assessed in
melan-a cells in hypoxia. (d) HREs in CTSL promoter were predicted. (e) Cells were transfected with luciferase reporter
vectors, pGL3-Ctsl/HRE or pGL3-Ctsl/mutHRE, and luciferase activity was determined under hypoxi conditions for
4 h. (f) ChIP-qPCR analysis for HIF1-α occupancy on CTSL promoter in m lan-a c lls in normoxa or hypoxia for .
Quantification of enrichment was represented as fold-enrich ent relative to IgG. Results are expressed as mean ± S.D of
more than three independent experiments. * p < 0.05. Student’s t-test.
2.2. Hypoxia Mimicking Condition by DFO Treatment Also Stimulated the Nuclear Expression of
HIF-1α Protein and CTSL Expression in Melan- Cells
Deferoxamine (DFO), an iron chelator, is known to upregulate the expression of HIF-
1α by mimicking the hypoxic environment [14,21]. The findings of cell viability assays
indicate that DFO treatment do s not i duce cytotoxicity at concentrations below 100 µM
(Figure S1a). Furth rmore, the DFO treatmen of melan-a cells significantly increased
the nuclear expression f HIF-1α prot in (Figure S1b) and CTSL transcripts (Figur S1c).
Mor over, th protein levels of CTSL and LC3 II were increased after DFO treatment
(Figure S1d). These results indicate th t DFO induces HIF-1α and CTSL in melan-a cells.
2.3. HIF-1α and CTSL Are Induced in Melan-a Cells under Starvation Conditions
Previous studies have shown that CTSL participates in autophagy [22]. To evaluate
the role of CTSL in autophagy and its association with HIF-1α in melanocytes, a starvation
model was employed to induce autophagy. Melan-a melanocytes were cultured under
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starvation conditions, and the mRNA and protein levels of HIF-1α and CTSL were eval-
uated. Our results reveal that as the starvation time increased, the mRNA levels of both
the molecules were also enhanced (Figure 2a). In addition, the conversion of pro-CTSL to
mature CTSL was significantly increased with starvation, as shown by Western blotting
analysis (Figure 2b). To verify the effect of HIF-1α on CTSL expression, melan-a cells
were pre-treated with cryptotashinone (CT), an HIF-1α inhibitor, and cells were under
starvation. The augmented expressions of HIF-1α and CTSL at the transcript (Figure 2c)
and mature CTSL at protein (Figure 2d) levels under starvation conditions were attenuated
in the presence of CT. These results imply that HIF-1α is closely related to CTSL expression
in melan-a melanocytes.
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2.4. CTSL Is Associated with Melanosome Degradation Through Autophagy in Melan-a Cells 
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Figure 2. HIF-1α and CTSL induction was enhanced by starvation condition in melan-a cells. (a) mRNA levels of HIF-1α
and CTSL were evaluated under starvation control. Moreover, (b) the protein level of CTSL was examined. Melan-a
cells were pretreated with CT for 1 h and (c) mRNA levels of HIF-1α and CTSL were determined under starvation for
24 h. (d) Protein level of CTSL was also confirmed. Results are expressed as mean ± S.D of more than three independent
experiments * p < 0.05. Stud nt’s t-test.
2.4. CTSL Is Associated with Melanosome Degradation through utophagy in elan-a ells
Analysis of elan–a cells subjected to starvation conditions has shown that starvation
induces the conversion of LC3 I to LC3 II, a central protein in autophagy, as ell as a
decrease in the p62 levels in these cells. In addition, starvation decreased the protein
levels of gp100 and tyrosinase in melan-a cells (Figure 3a). To identify the role of CTSL
in melanocytes in association with autophagy and melanosome regulation, the melan-a
cells were treated with Z-FF-FMK, an inhibitor that prevents the conversion of pro-CTSL
into mature CTSL. As a result, the conversion of CTSL from the pro- to the mature form
was blocked by treatment with Z-FF-FMK. Furthermore, along with increased expression
of LC3 II, increased expression of gp100 was observed in melan-a cells upon treatment
with Z-FF-FMK (Figure 3b). Next, using tandem fluorescent-tagged LC3 (mRFP-GFP-LC3)
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plasmid, we examined the role of the mature form of CTSL in the starvation-induced
autophagy pathway in melan-a cells. Our results show that starvation induced autophagic
flux, based on the finding that the numbers of yellow and red puncta were increased in
melan-a cells. In accordance with a previous report, an inhibitor of CTSL conversion to the
mature form decreased the number of red puncta, suggesting that the accumulation of pro-
CTSL in lysosomes led to incomplete autophagy by lysosomal dysfunction (Figure 3c) [23].
These results suggest that the mature form of CTSL is important in the regulation of
autophagosome-lysosome fusion for the completion of autophagy.




Figure 3. CTSL is associated with melanosome degradation through autophagy in melan-a cells. (a) Protein levels of p62, 
LC3, PMEL/gp100, and tyrosinase were examined under starvation conditions. (b) Melan-a cells were treated with Z-FF-
FMK for 1 h and protein levels of CTSL, LC3, PMEL/gp100, and tyrosinase were evaluated. (c) After Z-FF-FMK pre-treat-
ment and starvation for 8 h, tandem fluorescent-tagged LC3 (mRFP-GFP-LC3) was observed by confocal microscopy. 
Yellow (autophagosome) and red (autolysosome). Scale bar: 10 μm. Results are expressed as mean ± S.D of more than 
three independent experiments. * p < 0.05. Student’s t-test. 
Figure 3. CTSL is associated with melan some degr dation through autophagy in melan-a cells. (a) Protein levels of
p62 LC3, PMEL/gp100, and tyrosinase were examined under starvation conditions. (b) Melan-a cells were treated with
Z-FF-FMK for 1 h and protein levels of TSL, LC3, PMEL/gp100, a d tyrosinase were evaluated. (c) After Z-FF-FMK
pre-treatment and starvation for 8 h, tandem fluorescent-tagged LC3 (mRFP-GFP-LC3) was observed by confocal microscopy.
Yellow (autophagosome) and red (autolysosome). Scale bar: 10 µm. Results are expressed as mean ± S.D of more than three
independent experiments. * p < 0.05. Student’s t-test.
We next evaluated the role of CTSL in melanosome degradation in association with
the autophagic pathway. Starvation increased the expression of LC3 II, and the conversion
of pro-CTSL to mature CTSL. When Z-FF-FMK was used, a decrease in the mature form
of CTSL and accumulation of LC3 II were observed, possibly due to decreased lysosomal
activity in the autophagic pathway. In addition, starvation decreased the expression of
gp100 and tyrosinase, while inhibiting the conversion of pro-CTSL to mature CTSL, results
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in the accumulation of gp100 and tyrosinase (Figure 4a). Additionally, confocal images
show that CTSL expression after 4 h-starvation was colocalized with gp100 whereas Z-
FF-FMK pre-treatment attenuated colocalized CTSL and gp100 induced by starvation
(Figure 4b). After 24 h-starvation, gp100 expression was significantly decreased compared
to control. When Z-FF-FMK was pre-treated, gp100 expression was not reduced even
under starvation (Figure 4c). These findings imply that starvation induced melanosome
degradation in melanocytes by inducing autophagy along with the increased conversion
of CTSL to the mature form. If conversion of CTSL into the mature form is blocked,
melanosome degradation by starvation-induced autophagy is inhibited, along with the
accumulation of LC3 II. Moreover, we treated CTSL siRNA to melan-a cells to confirm the
role of CTSL in lysosomal degradation of LC3II at the lysosomal level. CTSL-knockdown
cells showed significantly higher expressions of LC3II and melanosome markers (gp100
and tyrosinase) compared to scramble siRNA-treated melan-a cells (Figure 4d,e). This
result confirms that CTSL is involved in autophagy and melanosome degradation.




Figure 4. Inhibition of CTSL activity led to accumulation of melanosome-related molecules in melan-a cells. (a) After Z-
FF-FMK pre-treatment and starvation for 24 h, CTSL, LC3, PMEL/gp100, and tyrosinase protein expressions were deter-
mined. (b) CTSL and gp100 expressions were observed by confocal microscopy after Z-FF-FMK pre-treatment and star-
vation for 4 h. Scale bar: 10 μm. (c) gp100 expression was observed by confocal microscopy after Z-FF-FMK pre-treatment 
and starvation for 24 h. Scale bar: 10 μm. (d) Confocal image of melan-a cells after scramble (scr) siRNA or CTSL siRNA 
treatment for 48 h. Scale bar: 20 μm. (e) CTSL, LC3, PMEL/gp100, and tyrosinase protein expressions were evaluated after 
scramble (scr) siRNA or CTSL siRNA treatment for 48 h. Results are expressed as mean ± S.D of more than three inde-
pendent experiments. * p < 0.05. Student’s t-test. 
2.5. The Regulation of CTSL Transcription by HIF-1α Was Also Detected in NIH-3T3 Cells 
The association of HIF-1α with CTSL observed in the melan-a cells was further eval-
uated in the NIH-3T3 cells, mouse fibroblast cell line. First, DFO was applied to the NIH-
3T3 fibroblast cell line to determine cell viability using the MTT assay (Figure S2a). We 
then evaluated the translocation of HIF-1 α into the nucleus using Western blot analysis. 
Our results showed the clear enhancement of nuclear fractions of HIF-1α protein in the 
Figure 4. Inhibition of CTSL activity led to accumulation of melanosome-related molecules in melan-a cells. (a) After
Z-FF-FMK pre-treatment and starvation for 24 h, CTSL, LC3, PMEL/gp100, and tyrosinase protein expressions were.
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determined (b) CTSL and gp100 expressions were observed by confocal microscopy after Z-FF-FMK pre-treatment and
starvation for 4 h. Scale bar: 10 µm. (c) gp100 expression was observed by confocal microscopy after Z-FF-FMK pre-
treatment and starvation for 24 h. Scale bar: 10 µm. (d) Confocal image of melan-a cells after scramble (scr) siRNA or
CTSL siRNA treatment for 48 h. Scale bar: 20 µm. (e) CTSL, LC3, PMEL/gp100, and tyrosinase protein expressions were
evaluated after scramble (scr) siRNA or CTSL siRNA treatment for 48 h. Results are expressed as mean ± S.D of more than
three independent experiments. * p < 0.05. Student’s t-test.
2.5. The Regulation of CTSL Transcription by HIF-1α Was Also Detected in NIH-3T3 Cells
The association of HIF-1α with CTSL observed in the melan-a cells was further evalu-
ated in the NIH-3T3 cells, mouse fibroblast cell line. First, DFO was applied to the NIH-3T3
fibroblast cell line to determine cell viability using the MTT assay (Figure S2a). We then eval-
uated the translocation of HIF-1 α into the nucleus using Western blot analysis. Our results
showed the clear enhancement of nuclear fractions of HIF-1α protein in the cells treated
with DFO (50, 100, and 200 µM) (Figure S2b). mRNA levels of CTSL were increased upon
treatment with DFO at the indicated concentrations (Figure S2c). Additionally, DFO treat-
ment significantly enhanced the luciferase activity in pGL3-Ctsl/HRE-transfected NIH-3T3
cells, whereas luciferase activity remained unchanged in pGL3-Ctsl/mutHRE-transfected
cells (Figure S2d). These findings imply that the promoter sequence encompassing the
HIF-1α binding site is closely related to Ctsl gene transcription, indicating that HIF-1α
controls the transcription of the Ctsl gene.
mRNA expressions of HIF-1α and CTSL significantly were increased after 24 h treat-
ment with DFO (Figure S3a). In addition, the protein levels of HIF-1α and CTSL (proform)
were also induced with an increased incubation time of DFO treatment (Figure S3b). To
verify the effect of HIF-1α on CTSL expression, the NIH-3T3 cells were treated with CT
prior to DFO treatment. Our results indicated that DFO treatment activated the expression
of HIF-1α and CTSL at the transcript (Figure S3c) and protein levels (Figure S3d), whereas
the expression of HIF-1α and CTSL, which were induced by DFO treatment, were abolished
in CT-pre-incubated NIH-3T3 cells.
To determine the role of CTSL in autophagy and apoptosis, NIH-3T3 cells were
treated with Z-FF-FMK and cell viability was assessed. Adding Z-FF-FMK to DFO-treated
cells results in remarkably decreased cell viability as compared to DFO-only treated cells,
suggesting that the conversion of CTSL to the mature form could be involved in the
regulation of the viability of cells (Figure S4a). Subsequently, we examined the changes in
the expression of CTSL, LC3 (Figure S4b) and cleaved caspase-3 (Figure S4c), an apoptosis-
related molecule, following treatment with DFO and Z-FF-FMK. Our data revealed that
Z-FF-FMK pretreatment of DFO-treated cells shows significantly higher levels of LC3 II
conversion and cleaved caspase-3, while no increase was observed in the mature form of
CTSL, as compared to DFO-only treated cells. These results suggest that the mature form
of CTSL might play an important role in the regulation of cell survival and the autophagy
pathway.
3. Discussion
The present study has demonstrated that CTSL transcription is regulated by HIF-1α
expression. Moreover, the HIF-1α induced-expression of CTSL is involved in lysosomal
dynamics that are associated with the autophagy pathway and melanosome degradation
in melanocytes. Previously, CTSB, another cathepsin molecule, was studied as a target of
HIF-1α in HepG2 cells [12]. However, there is no report on whether CTSL is regulated by
HIF-1α. In our study, we have shown that hypoxia or hypoxia-mimicking conditions by
DFO treatment trigger the expression of HIF-1α and CTSL in melan-a cells and NIH-3T3
cells. In particular, the role of HIF-1α in the regulation of CTSL expression was confirmed
via a luciferase gene reporter assay. Furthermore, the regulation of HIF-1α-induced CTSL
expression was verified by experiments involving the use of an HIF-1α inhibitor.
HIF-1α is important in skin physiology and pathophysiology because skin, under a
relatively hypoxic environment, favors increased expression of HIF-1α, which regulates
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a variety of biological processes in the skin [24]. Under normoxic conditions, prolyl-
4-hydroxylases (PHDs) hydroxylate HIF-1α and bind with von Hippel–Lindau protein
(pVHL), which is an E3 ubiquitin ligase. Then, hydroxylated HIF-1α is processed to
proteosomal degradation. Under hypoxic conditions, PHDs are inactivated, and HIF-1α
is translocated to the nucleus, where it binds to the HRE of target genes promoters to
induce transcription [25,26]. HIF-1α is found to regulate the expression of hundreds of
genes involved in many physiological functions, including angiogenesis, cell survival,
migration, metastasis, and glycolysis [27]. In the skin, HIF-1α plays an important role in
the adhesion and migration of keratinocytes. Further, HIF-1α knockdown in keratinocytes
leads to a decreased expression of laminin-332, α6 integrin, and β1 integrin, which induces
dysregulated cell proliferation, colony-forming efficiency, and cell cycle arrest [28].
In our study, we have reported that CTSL transcription is regulated by the binding
of HIF-1α to the HREs present on the CTSL promoter. Our promoter analysis has re-
vealed three putative candidate consensus HREs in the CTSL promoter, which led to the
hypothesis that CTSL could be one of the HIF-1α target genes. Based on the outcomes
of the luciferase gene reporter assay, it was evidently shown that the putative HREs in
the CTSL promoter regulate the transcription of CTSL in an HIF-1α dependent manner.
Moreover, HIF-1α-mediated CTSL expression was confirmed by experiments using an
HIF-1α inhibitor. CTSL degrades cellular proteins through the endolysosomal pathway.
Moreover, CTSL participates in the autophagic pathway by degrading autophagosome
markers LC3 II and GABARAP-II [29]. Our results have shown that starvation induces
the conversion of LC3 I to LC3 II, along with an increased expression of the mature form
of CTSL. Moreover, an inhibitor that prevents the conversion of CTSL to the mature form
induces the accumulation of LC3 II by blocking LC3 II degradation through the progression
from autophagosomes to autolysosomes in the autophagic pathway. A previous study
also revealed that the inhibition of CTSL activity induces impaired autophagy, which is
mediated by lysosomal dysfunction [23]. In accordance with the findings of a previous
report, the accumulation of pro-CTSL without conversion to the mature form inhibits
the lysosomal degradation, leading to lysosomal dysfunction and abnormal autophagic
pathways. Therefore, CTSL activity might be important for the completion of autophagy
by autophagosome–lysosome fusion.
Along with the effect of CTSL on autophagic signaling, HIF-1α is also known to be
associated with autophagy signaling. Autophagy is a mechanism by which cytoplasmic
materials, such as damaged or unnecessary organelles, are processed by double membrane
vesicles called autophagosomes, and delivered to the lysosomes. This signaling pathway is
responsible for removing and recycling the dysfunctional cellular materials [30]. It has been
reported that autophagy is activated under hypoxic conditions, leading to the induction
of HIF-1α. This process protects the cells from hypoxic conditions, facilitating oxygen
homeostasis [31]. Our results also show that HIF-1α induction promotes CTSL expression
and leads to autophagy. Taken together with previous studies, the findings of our study
reinforce that HIF-1α under hypoxic conditions is closely related to autophagic signaling.
We have also validated the effect of CTSL on melanosome homeostasis. Melanosomes
are important organelles for melanin production and include tyrosinase and tyrosinase-
related proteins, which play critical roles in melanogenesis [32,33]. Many studies have
demonstrated that autophagy participates in the MITF-target gene regulation, melanosome
biogenesis, and melanosome degradation [34–36]. In particular, it has been reported that
melanosome degradation in keratinocytes, as well as melanocytes, can be controlled by
the regulation of autophagic activity [37,38]. Moreover, melanosomes may become unsta-
ble when CTSL is absent because melanosomes exhibit lysosomal characteristics [20,33].
Our observations have also confirmed that CTSL-induced autophagic signaling results
in reduced gp100 expression, and the inhibition of CTSL maturation stimulates the accu-
mulation of LC3 II without further progression from autophagosomes to autolysosomes
by the autophagosome–lysosome fusion. In addition, melanosomes are also accumulated
through the impairment of autophagy completion by lysosomal dysfunction. According
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to previous studies, cathepsin V, another cathepsin molecule, is reported to play a vital
role in pigmentation. The expression of cathepsin V, known as CTSL2, has been reported
to be higher in keratinocytes from light skin than in those from dark skin, even though
there was no difference in the expression of various subtypes of cathepsin such as CTSL,
CTSL2, and CSTB in melanocytes between light and dark skins [39]. Moreover, CTSV
expression has been reported to be involved in melanosome degradation [40]. Therefore,
CTSL as a lysosomal enzyme, which was examined in this study in association with HIF-1α,
might also play a crucial role in the regulation of melanosomal degradation through the
autophagy pathway.
Taken together, the current study highlights that CTSL is a novel target gene of HIF-1α
and plays a pivotal role in melanosome homeostasis through the autophagic pathway.
We believe that the findings from this study provide a useful resource for studying the
HIF-1α-CTSL axis and its involvement in the autophagy pathway in melanocyte biology.
4. Materials and Methods
4.1. Cell Cultures
NIH-3T3 fibroblasts, derived from mouse embryonic fibroblast cells, were cultured
in Dulbecco’s modified Eagle’s medium (DMEM, Welgene, Daegu, Republic of Korea)
with 10% fetal bovine serum (FBS, Welgene) and 1% penicillin-streptomycin (Welgene).
Melan-a, a highly pigmented non-tumorigenic mouse melanocytic cell line, was kindly
provided by Prof. Dorothy C. Bennett (St George’s Hospital Medical School, London, UK).
The cells were maintained in RPMI 1640 growth medium (Welgene), supplemented with
10% FBS, 1% penicillin-streptomycin, and 200 nM 12-O-tetradecanoylphorbol-13-acetate
(TPA; Sigma-Aldrich, St Louis, MO, USA). Cells were maintained at 37 ◦C in a humidified
5% CO2 incubator. For hypoxia, cells were grown in a hypoxia incubator at 37 ◦C in 1% O2
and 5% CO2.
4.2. Reagents
Deferoxamine mesylate salt (DFO), Z-FF-FMK, and cryptotanshinone (CT) were pur-
chased from Sigma-Aldrich (St Louis, MO, USA).
4.3. Dual Luciferase Assay
The consensus sequence of the three HRE sites in the −2000 bp fragment of the mouse
CTSL promoter were mutated by substituting CG or GC with AA. The DNA fragment
was cloned into vector pGL3 to generate pGL3-Ctsl/HRE or pGL3-Ctsl/mutHRE. Melan-a
and NIH-3T3 cells were seeded onto 96-well plates at a density of 5 × 103 cells/well, and
allowed to attach for 24 h. Next, cells were transfected with pGL3-HRE-luciferase construct
(pGL3-Ctsl/HRE or pGL3-Ctsl/mutHRE). After transfection, cells were treated with DFO
or under hypoxia condition before reporter assay. Luciferase assays were performed
using the Dual-Glo Luciferase Assay System (Promega, Madison, WI, USA), according to
the manufacturer’s instructions. Luminescence was measured using a microplate reader
(Centro XS LB 960, Berthold, Freiburg, Germany).
4.4. Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation was carried out with Pierce Agarose ChIP Kit (Thermo
Scientific, Waltham, MA, USA) according to the manufacturer’s protocol. Immunoprecipi-
tation was performed using HIF1α-specific antibodiy (Invitrogen, Carlsbad, CA, USA). The
eluted DNA was used as a template for quantitative PCR (qPCR) using primers specific
for the CTSL promoter, CTSL1 (forward: 5′-GAAATTCCACAGCAGGCCTT-3′, reverse: 5′-
CTGTGGTGCAAGCCTTGG-3′), CTSL2 (forward: 5′-TCCATGTATAGGTAAGGCAGGA-
3′, reverse: 5′-AAGACAGAGCGGAGGACAGA-3′), and CTSL3 (forward: 5′-CCTGTTCCA
ATGACTACTAGGC-3′, reverse: 5′-AGCCCAGCAGTAAACCGTT-3′).
Int. J. Mol. Sci. 2021, 22, 8596 10 of 13
4.5. MTT Assay
Cell viability was estimated by colorimetric assay, using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT; Sigma-Aldrich) for incubation (4 h, 37 ◦C). The
supernatant was discarded and replaced with dimethyl sulfoxide (DMSO) to dissolve
cytoplasmic formazan crystals. Absorbance was measured at 570 nm using a microplate
reader (SpectraMax 340; Molecular Devices LLC, Sunnyvale, CA, USA).
4.6. Quantitative Real-Time RT-PCR
Total cellular RNA was isolated using an RNeasy Plus Mini Kit (QIAGEN, Valencia,
USA). cDNA was generated from 0.5 µg total RNA using a kit (PrimeScript 1st strand
cDNA Synthesis Kit; Takara Bio Inc., Japan) according to the manufacturer’s protocol.
The resulting cDNA was used for quantitative PCR amplification and specific sequence
detection with an Applied Biosystems Step One Real-Time PCR System (Life Technologies
Japan Ltd., Japan). The PCR reaction was performed using Power SYBR® Green PCR
Master Mix (Applied Biosystems, Foster City, USA). The relative expression of beta actin
was used to standardize the reaction. The following primer pairs, specific to HIF1α,
cathepsin L, and beta actin, were used to amplify cDNA: mouse HIF1α: forward (5′-
ACCTTCATCGGAAACTCCAAAG-3′), reverse (5′-CTGTTAGGCTGGGAAAAGTTAGG-
3′); mouse cathepsin L: forward (5′-ATCAAACCTTTAGTGCAGAGTGG-3′), reverse (5′-
CTGTATTCCCCGTTGTGTAGC-3′); mouse beta actin: forward (5′-GGCTGTATTCCCCT
CCATCG-3′), reverse (5′-CCAGTTGGTAACAATGCCATGT-3′). For each sample, real-time
PCR was performed in triplicate.
4.7. Cell Starvation
Cells were washed three times with pre-warmed PBS, then incubated in starvation
medium (RPMI 1640 growth medium with 1% penicillin-streptomycin) at 37 ◦C under 5%
CO2.
4.8. Western Blotting
Whole-cell extracts were prepared in RIPA buffer (Tris-buffered saline, 0.5% deoxy-
cholate, 0.1% SDS, 1% Triton X-100) containing a protease inhibitor cocktail (GenDEPOT,
Barker TX, USA). The cytoplasmic and nuclear fractions of cells were obtained using the
NE-Per® reagents (Thermo scientific, Bremen, Germany), according to the manufacturer’s
instructions. Proteins isolated from cells were separated by SDS-PAGE. The separated pro-
teins were then transferred to nitrocellulose membranes according to standard procedures.
The membranes were blocked with 5% v/v skim milk in a TBS-T buffer (TBS with 0.1%
w/v Tween-20) and reacted with primary antibodies overnight at 4 ◦C. Primary antibodies
against HIF1α (Cayman Chemical, Ann Arbor, MI, USA), cathepsin L (R&D, Minneapolis,
USA), cleaved caspase3, PMEL/gp100 (abcam, Cambridge, UK), Tyrosinase (Santa Cruz
Biotechnology, Dallas, TX, USA), LC3 (Novus Biologicals, Littleton, CO, USA), p62 (Cell
signaling Technology, Danvers, MA, USA), and LAMP1 (abcam) were used at a 1:1000
dilution. GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and TBP (abcam) were
used as a control for protein loading. The membranes were then washed three times for
10 min with the TBS-T buffer and incubated for 1 h with 1% skim milk in TBS-T buffer
containing horseradish peroxidase-conjugated secondary antibodies (diluted 1:3,000). The
proteins were visualized using an ECL system (Thermo Scientific, Franklin, MA, USA).
Signal density was quantified using Image J software (US National Institutes of Health,
Bethesda, MD, USA).
4.9. Transfection and Plasmids
The mRFP-eGFP-LC3 construct was kindly provided by Dr. Tamotsu Yoshimori
(Osaka University, Osaka, Japan). Cells were seeded into a chamber slide and cultured
overnight. Melan-a cells were transfected with ptfLC3-expressing plasmid using TransIT-
2020 Transfection reagent according to the manufacturer’s protocol (Mirus, Madison, WI,
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USA). The cells were then washed in PBS and fixed in freshly prepared 4% paraformalde-
hyde. After three washes in PBS, the cells were mounted with DAPI. Autophagic flux was
determined based on patterns of GFP and RFP puncta under a Zeiss confocal lase-scanning
microscope.
4.10. Confocal Microscopy
Melan-a cells were washed in PBS and fixed (15 min) in 4% paraformaldehyde. Sam-
ples were then washed in PBST (PBS with 0.1% Tween-20) and incubated overnight (4 ◦C)
in anti-cathepsin L (R&D), or gp100 (abcam), followed by three washings in PBST and
incubation (1 h) with the appropriate secondary antibody. All samples were mounted in
4′,6-diamidino-2-phenylindole solution (DAPI; Vector Laboratories Inc., Burlingame, CA,
USA.). Slides were evaluated with confocal microscopy (LSM 700; Carl Zeiss, Oberkochen,
Germany).
5. Statistical Analysis
All graphs represent the mean ± standard deviation (SD) of experiments performed
more than triplicate. Data were compared using two-tailed Student’s t-test. Standard
software (SPSS; SPSS Inc., Chicago, IL, USA) was employed, with the cutoff for statistical
significance set at p < 0.05 (denoted by * in the figures).
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/ijms22168596/s1, Figure S1: HIF-1α and CTSL induction was enhanced by DFO treatment in
melan-a cells, Figure S2: Hypoxic-mimic condition by DFO promoted HIF-1α and CTSL activation in
NIH-3T3 cells, Figure S3: HIF-1α induction regulated CTSL expression, Figure S4: CTSL is involved
in cell associated autophagy induction.
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HRE Hypoxia response elements
VEGF Vascular endothelial growth factor
TGF-β Transforming growth factor-β
PGK1 Phosphoglycerate kinase 1
CTSB Cathepsin B
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CTSK Cathepsin K
COVID-19 Coronavirus (SARS-CoV-2) disease
DFO Deferoxamine
CT Cryptotashinone
LC3 Microtubule-associated protein 1 light chain 3
PHDs Prolyl-4-hydroxylases
pVHL von Hippel–Lindau protein
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